Mark Fielding

I have a PhD in organic chemistry and joined AstraZeneca as a drug substance process development lead for synthetic pharmaceuticals. Following this, I moved into regulatory CMC and have since had oncology project lead roles covering the entire project lifecycle. More recently I have played a lead role in the regulatory CMC development of radiopharmaceuticals within AstraZeneca and am active in external trade associations, to help shape external guidance in this field.